Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.7 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.1 | 0.7 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |